Client: Hikma Pharmaceuticals
With a solid understanding of the product, market and audience, one of our priorities was to increase awareness of the active ingredients in Advair Diskus® and Hikma’s generic Fluticasone Propionate and Salmeterol Inhalation Powder, USP are the same. The noticeable difference for patients is the inhaler device. Hikma worked with Vectura Group to develop the proprietary dry powder inhaler and formulation technology.
Responsory’s pharmaceutical team then worked briskly behind the scenes to help the multinational company create a brand identity, collateral and website where patients would find product information along with an “Instructions for Use” guide to educate patients on how to effectively administer the medication.